What are the current guidelines for tetanus prophylaxis and management, including the use of tetanus toxoid vaccine (Td or Tdap) and tetanus immune globulin (TIG) for various wound types and established tetanus infection?

Tetanus Prophylaxis and Management Guidelines

Wound Management: The Core Algorithm

For tetanus prophylaxis in wound management, the decision depends on two factors: vaccination history (complete 3-dose primary series or not) and wound type (clean/minor versus all other wounds), with timing of last tetanus-containing vaccine determining need for booster. 1

Classification of Wounds

• Clean, minor wounds: Simple, uncontaminated injuries 1
• All other wounds (tetanus-prone): Wounds contaminated with dirt, feces, soil, or saliva; puncture wounds; avulsions; wounds from missiles, crushing, burns, or frostbite 1

Vaccination Decision Matrix

For patients with unknown or <3 doses of tetanus toxoid:

• Clean, minor wounds: Give tetanus toxoid-containing vaccine only (no TIG) 1
• All other wounds: Give BOTH tetanus toxoid-containing vaccine AND TIG 250 units IM 1, 2

For patients with ≥3 doses (completed primary series):

• Clean, minor wounds: Give tetanus toxoid-containing vaccine only if ≥10 years since last dose 1
• All other wounds: Give tetanus toxoid-containing vaccine only if ≥5 years since last dose (no TIG needed) 1

Patients vaccinated <5 years ago with completed primary series require nothing for wound management. 1

Vaccine Selection for Wound Management

For persons ≥11 years requiring tetanus toxoid-containing vaccine, Tdap is preferred if they have not previously received Tdap or Tdap history is unknown. 1

• For pregnant women requiring vaccination: Use Tdap regardless of prior Tdap status 1
• For nonpregnant persons with documented prior Tdap: Use Td if tetanus vaccine indicated 1
• If Td unavailable: Tdap may be substituted 1
• For children <7 years: Use DTaP 1

The 2019 ACIP update allows either Td or Tdap for decennial boosters and wound management after initial Tdap dose, providing greater clinical flexibility. 1

Administration Details When Both Products Needed

When both TIG and tetanus toxoid-containing vaccine are indicated, administer using separate syringes at different anatomical sites. 1

• TIG dose: 250 units IM for all ages 1, 2
• Do not delay wound care to obtain vaccination history 1

Critical Special Populations

Immunocompromised Patients

Persons with HIV infection or severe immunodeficiency who have contaminated wounds should receive TIG regardless of their tetanus immunization history. 1

This represents a key deviation from standard protocols, as even fully vaccinated immunocompromised patients require passive immunization for high-risk wounds. 1

Patients with History of Arthus Reaction

Persons with prior Arthus reaction to tetanus toxoid-containing vaccine should not receive tetanus vaccine until >10 years after most recent dose, regardless of wound severity. 1

• TIG decision still based on primary vaccination history (give if <3 doses documented) 1
• This creates a clinical dilemma for contaminated wounds in under-vaccinated patients with Arthus history—TIG becomes the sole protection 1

Primary Immunization for Unvaccinated Adults

Adults who never received tetanus vaccination should receive a 3-dose series: one dose of Tdap, followed by Td at >4 weeks, then another Td at 6-12 months. 1

• Tdap can substitute for any dose in the 3-dose primary series 1
• Persons with unknown/uncertain vaccination history should be considered unvaccinated 1

Mass Casualty and Resource-Limited Settings

In mass casualty events with limited TIG supply, reserve TIG for patients least likely to have adequate vaccination: persons >60 years and immigrants from regions other than North America or Europe. 1

• When unable to confirm vaccination history in mass casualty setting and patient has tetanus-prone wound, give tetanus toxoid if TIG unavailable 1
• Most wounds in disaster settings are tetanus-prone due to environmental contamination 1

Common Pitfalls to Avoid

Do not assume military service equals complete vaccination—while those with U.S. military service since 1941 likely received at least one dose, completion of primary series cannot be assumed. 1

Do not give tetanus toxoid more frequently than indicated—boosters given <5 years apart for contaminated wounds or <10 years for clean wounds are unnecessary and can accentuate adverse effects. 1, 2, 3

Do not confuse timing of protection—tetanus toxoid given at time of injury protects against the NEXT injury, not the current one, as antibody response takes weeks to develop; TIG provides immediate passive protection. 4

Recognize that clinically determining "tetanus-prone" wounds is imperfect—tetanus has occurred after minor, seemingly innocuous injuries yet remains rare after severely contaminated wounds, supporting the algorithmic approach rather than clinical judgment alone. 4

Routine Booster Immunization

Routine tetanus-diphtheria booster recommended every 10 years after completing primary series. 1

• Either Td or Tdap acceptable for decennial booster per 2019 ACIP update 1
• No urgency for booster administration in acute injury setting if not otherwise indicated 4